Background and Purpose-Restenosis after carotid angioplasty (with or without stent) is associated with increased rate of stroke and death. Our aim was to determine risk and predictive factors related to carotid restenosis post carotid angioplasty and its association to recurrent cerebrovascular events. Methods-All consecutive patients with carotid stenosis treated with angioplasty (n=1060) in a single University Hospital were included (from 2002 to 2013). Follow-up was done prospectively evaluating restenosis, ipsilateral stroke, or death.
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C
arotid angioplasty (CA) and stenting has emerged as an alternative to carotid endarterectomy for the management of carotid stenosis. 1 Clinical trial results show mixed data, with rates of restenosis after CA ranging from 1% to 21%. [2] [3] [4] [5] Differences in restenosis rates are related to study design variability. Lack of stent use in some of them increases restenosis rate. A recent study reviews clinical trials published from 1990 to 2013 comparing CA stenting and carotid endarterectomy. Carotid restenosis rate was ≥50%, or occlusion ranged around 6% four years after carotid endarterectomy or CA stenting in this study. 6 This incidence is more accurate given the widespread stent use nowadays. In addition, severe carotid artery restenosis or occlusion after previous surgical or endovascular treatment is associated with an increased risk of recurrent cerebrovascular events. [2] [3] [4] Recent American Heart Association/American Stroke Association guidelines state that routine long-term follow-up imaging with carotid duplex ultrasonography is not recommended after revascularization. 7 Our aim was to determine the risk and predictive factors related to carotid restenosis post CA or CA stenting to identify a subset of patients who might benefit from close ultrasound monitoring during follow-up or more aggressive therapies to avoid restenosis.
Methods
Study Design
We analyze a prospective database of all consecutive patients treated by CA in our center in the period 2002 to 2013. The study was approved by our institutional review committee. The patients eligible for the study were those treated with CA (with or without stent) because of symptomatic or asymptomatic carotid artery stenosis or restenosis ≥70%, regardless of cause, and with possibility of follow-up. Every patient underwent a comprehensive interview, neurological examination, carotid duplex evaluation, and brain computed tomography or magnetic resonance imaging before angioplasty. Cerebrovascular
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August 2016 reactivity was evaluated by means of breath holding index. We considered values of breath holding index <0.69 as impaired. 8 Outpatient clinical and ultrasound follow-up was scheduled for 1, 3, and 6 months and annually thereafter for all patients to evaluate recurrent events and restenosis degree. The threshold for the diagnosis of severe restenosis (≥70%) was defined by peak systolic velocities of ≥300 cm/s and hemodynamics changes. Intervention protocol is detailed in the online-only Data Supplement.
Predictors of restenosis and association of restenosis and outcome were determined by Kaplan-Meier curves with the log-rank test. Independent predictors of restenosis were assessed by Cox regression analysis by forward-stepwise method, including in the first step those baseline variables associated at a P value under 0.1 in Kaplan-Meier analysis. We used SSPS 17.0 for statistical analysis. P<0.05 was considered statistically significant.
Results
From January 2002 to December 2013, 1196 patients underwent CA (with or without stent). There were 136 patients excluded from the study because of loss of follow-up. Final sample was 1060 patients. Baseline characteristics of patients and selected sample are shown in Table I and Figure I in the online-only Data Supplement.
Ninety-seven patients (9.2%) experienced ≥70% restenosis during follow-up. Of them, 47 restenosis patients (48.2%) underwent a new angioplasty during follow-up. Mean restenosis time was 12 months. Age older than 70 years (P=0.003) and history of hypertension (P=0.002) were the only vascular risk factors significantly related to higher rates of restenosis during follow-up (Table II in the online-only Data Supplement). Regarding angioplasty and ultrasound variables, angioplasty without stent (P<0.0001), postprocedure stenosis >30% (P<0.0001), and preprocedure impaired cerebral vasoreactivity (P=0.003) were also related to restenosis (Table III in the online-only Data Supplement).
Association of hypertension and age >70 years was related to higher restenosis rates (13.9%; P=0.003). Furthermore, patients with hypertension and impaired vasoreactivity (IVR) showed higher values of restenosis (14.8%; P=0.006; Figure 1 Figure 2 ).
When excluding from analysis those procedures without stent and those performed in restenosis, the final sample size was 992 patients. After Cox regression analysis, age appeared as independent risk predictors of ≥70% restenosis (HR, 1.8 [1.18-2.85]; P=0.007), together with hypertension and IVR that still were present in the final model (Table IV -VII in the online-only Data Supplement).
Discussion
Post-angioplasty restenosis is the most common late complication of this procedure. Our results provide various key findings. First, restenosis rate of our sample (9.2%) is higher than that of CREST (Carotid Revascularization Endarterectomy vs Stenting Trial) study (6%) but within the ranges reported in previous studies and still is a too frequent noncontrolled complication. Second, restenosis is independently associated with hypertension, impaired preprocedure vasoreactivity, and angioplasty without stent. Third, in our cohort, restenosis was associated with an increased risk of ipsilateral stroke. Globally, our results pointed out to a high-risk subgroup, which might benefit from a closer follow-up with carotid imaging.
Recent theories explain atherosclerotic disease as an entity based on inflammation response to endothelial dysfunction. Such dysfunction involves smooth muscle cell proliferation and neointimal hyperplasia. 9 Hypertension is a known risk factor that triggers endothelial damage. The occurrence of restenosis is related to hypertension, probably because high 
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blood pressure promotes smooth muscle cell proliferation in treated vessels. Angioplasty alone is no longer the standard of care; however, some procedures involve technical difficulties that prevent stent use. The inclusion of some restenosis procedures and angioplasty without stent could explain, at least in part, the higher rate of restenosis detected compared with the CREST study. Nevertheless, stent use results in a more effective long-term restenosis prevention technique.
In addition, we found that hypertension and >70-year-old patients and hypertensive patients with IVR showed the highest restenosis rates during follow-up. The association of risk factors mentioned will allow us to detect patients at greater risk of restenosis. However, further validation of our results is necessary to select patients for closer monitoring in daily practice.
Cerebral vasoreactivity measures the blood flow autoregulation, and it is an essential property of brain endothelium to maintain a constant metabolism. 10 Altered cerebral vasoreactivity reveals a dysfunction in vascular cerebral compensation mechanisms because of myointimal hyperplasia, which increases arterial wall stiffness. Previous studies have observed the association between impaired cerebrovascular reactivity and compromised endothelial function.
10,11 IVR could be considered an ultrasonographic marker of endothelial dysfunction in small-vessel compensation mechanisms. Preprocedure IVR express endothelial dysfunction in small vessels and could suggest a common inflammatory mechanism to the large vessels with restenosis. To the best of our knowledge, this is the first description of a relation between vasoreactivity and carotid restenosis.
Finally, ipsilateral stroke was more frequent in restenosis patients. According to recent CREST analysis, 3 patients who had restenosis were at greater risk for ipsilateral stroke after the periprocedural period up to the end of follow-up than were those who did not have restenosis (HR, 4.37, 95% confidence interval, 1.91-10.03; P=0.0005).
We hypothesize that high-risk restenosis patients would need early closer monitoring, given the increased rate of ipsilateral stroke detected in those patients. The identified risk factors for restenosis in this group of patients will allow us to determine the right strategy to minimize and even avoid its consequences.
The main limitation of the current study is related to the retrospective analysis of the prospectively recorded data, causing an ascertainment bias that cannot be ruled out. Another limitation is the use of ultrasound velocity threshold for detection of restenosis that is not as accurate as angiography, but it is feasible for repeated evaluation and widely accepted in guidelines.
Conclusions
Carotid restenosis is related to hypertension, IVR, and angioplasty without stent. Based on our data, cerebral vasoreactivity emerges as a new ultrasonographic marker of the endothelial dysfunction, which predisposes restenosis. Supplemental Tables  4-9 Supplemental References 9
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Study Design Every patient underwent a comprehensive interview, neurological examination, carotid duplex evaluation, and brain CT or MRI before CAS. All subjects underwent transcranial Doppler (TCD) assessment of intracranial vessels using Toshiba TM Aplio 500 Platinum series ultrasound device with a 2 Mhz transducer. Also, pre-procedure ultrasound protocol in our center includes cerebrovascular reactivity which was evaluated in 84.4 % (895) of the sample. Only in 15.6 % (165) of the patients, cerebral reactivity was not assessed due to technical problems or lack of patient collaboration. Vasoreactivity was performed by means of BH index (BHI). The TCD examinations included the transtemporal insonation of the MCA, the anterior carotid artery, and the carotid siphon to exclude additional intracranial stenosis of a vessel supplied by the internal carotid artery. Cerebrovascular reactivity to hypercapnia was evaluated by means of the breath-holding index (BHI). Two dual 2-MHz transducers fitted on a headband and placed on the temporal bone windows were used to obtain a bilateral continuous measurement of mean flow velocity in the middle cerebral arteries. Depth of insonation ranged from 48 to 52 mm. The BHI is obtained by dividing the percentage increase in mean flow velocity occurring during breath holding by the length of time (seconds) subjects hold their breath after a normal inspiration ([mean flow velocity at the end of breath holding minus mean flow velocity at rest divided by mean flow velocity at rest] multipled by 100 divided by seconds of breath holding) [1] [2] . We considered values of BHI < 0.69 as impaired [2] .
Intervention Protocol
Symptomatic carotid stenosis was characterized by TIA or non-disabling stroke (defined by modified Rankin scale ≤ 2) ipsilateral to the index lesion. Asymptomatic patients were treated if they had (1) progressive stenosis ≥ 70% developing in follow-up examinations, (2) asymptomatic stenosis ≥70% with contralateral occlusion, (3) diminished or exhausted cerebral vasoreactivity, (4) presence of microembolic signal (MES) in the ipsilateral middle cerebral artery on transcranial doppler imaging, (5) silent ipsilateral ischemic lesions in computed tomography (CT) or MRI scans, and/or (6) scheduled cardiac surgery. Exclusion criteria were: (1) absence of informed consent, (2) intraluminal thrombus over the stenosis, or (3) carotid angioplasty performed during an endovascular acute stroke treatment According to the protocol followed in our department [3] all patients were on aspirin (100 mg/d) and clopidogrel (75 mg/d) for at least 3 days before the intervention. Briefly, a 6-F, 90-cm long sheath was positioned in the common carotid artery (CCA). For cerebral protection, 2 types of filters were used: FilterWire EZ (Boston Scientific, Natick, MA, USA) and Spider Embolic Protection Device (ev3 Inc., Plymouth, MN, USA). Predilatation of the stenosis with a 2-to 3-mm balloon catheter was performed after distal filter placement in all patients, and a self-expanding stent [Carotid Wallstent (close cell stent) (Boston Scientific) or Acculink (open cell stent) (Abbott Vascular, Redwood City, CA, USA)] was deployed. Postdilation with a 5-to 6-mm balloon was performed in cases with residual significant stenosis, mainly in patients without concomitant hemodynamic complications. Residual stenosis (immediately post-procedure) was defined using North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria in subtraction angiography. [4] The in-stent luminal diameter was compared with the distal non-tapering portion of the ICA serving as the reference segment to identify residual stenosis. Atherosclerotic plaque characterization was done using digital subtraction angiography images. [5] .
Patients underwent a new CAS when carotid restenosis became symptomatic (6.3 %) and in case of residual stenosis degree progressions with contralateral carotid artery occlusion during follow up (93.6 %).
Post-stent medical management included, high dose statin (ie Atorvastatin), dual antiplatelet therapy for one month, and simple antiplatelet therapy thereafter. Blood pressure goal after procedure was 140 mmHg of Systolic blood pressure and 90 mmHg diastolic blood pressure. 
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